The latest annual report from the National Cancer Institute offers a glimpse of hope in America’s ongoing battle against cancer. Showing positive trends, both new cancer diagnoses and cancer-related deaths are on a downward slope. From 2018 to 2022, cancer death rates dropped by 1.7% each year for men and 1.3% for women.
Dr. Marc Siegel from Fox News pointed out that the decline in cancer deaths among both men and women results from various factors. These include improved screening, early intervention, and advancements in surgical and targeted therapies. Smoking-related cancers, such as those affecting the lung, bladder, and larynx, have seen significant declines due to reduced tobacco use and updated screening guidelines.
In men, cancer mortality rates for common types like prostate, liver, and esophagus have decreased. Lung cancer deaths, in particular, dropped by 4.5% annually during this period. However, there are some cancers in men, like those of the pancreas and bones, where death rates have unfortunately increased.
Women also experienced reduced death rates in several cancer types, including the brain, cervix, and breast. The most significant decline in cancer deaths for women was in lung and bronchus cancer, which fell by 3.4% each year. However, some cancers, such as those affecting the oral cavity and liver, saw increased death rates.
For younger populations, the trend is also promising. Child cancer death rates fell by 1.5% per year from 2001 to 2022. Among teenagers and young adults, cancer-related mortality decreased by 2.9% annually from 2001 to 2005 and continued to decline, though the rate of decline slowed from 2005 to 2020.
New cancer diagnoses in men decreased annually by up to 2.2% between 2001 and 2013. However, from 2013 to 2021, these rates remained relatively stable. Despite this, some cancers, such as prostate cancer, have seen an increase in new cases.
Women’s new cancer cases rose slightly by 0.3% each year from 2003 to 2021. The report highlights increases in certain types, including breast, melanoma, and liver cancers. Researchers attribute some of this rise to lifestyle factors like obesity and alcohol consumption.
The report also sheds light on how new classifications of tumors, such as gastrointestinal stromal tumors, have affected statistics. As understanding of these tumors improves, they are now recognized as malignant, impacting the observed cancer rates.
For children, the numbers are encouraging, with a slight annual decrease in new cancer cases between 2017 and 2021. Brain and nervous system cancers saw the steepest decline, though there were slight increases in leukemia and lymphoma cases.
Overall, these findings suggest that while challenges remain, significant progress is being made in cancer prevention and treatment. This progress is largely driven by medical advancements and lifestyle changes that are positively impacting cancer trends across different demographics.
